<HTML lang="en" dir="ltr" class="client-nojs">
<style type="text/css">
A:before { content:' '; } 
A:after { content:' '; } 
SPAN:before { content:' '; } 
SPAN:after { content:' '; } 
</style>
<BODY class="mediawiki ltr sitedir-ltr ns-0 ns-subject page-Team_Queens_Canada_Improve skin-igem action-view"><DIV id="globalWrapper"><DIV id="content" class="mw-body" role="main"><DIV id="top_title"><H1 id="firstHeading" class="firstHeading"><SPAN dir="auto">Team:Queens Canada/Improve</SPAN></H1></DIV><DIV id="HQ_page"><DIV id="bodyContent"><DIV id="mw-content-text" lang="en" dir="ltr" class="mw-content-ltr"><DIV class="containerMenu"><DIV class="navbar-header"><A type="button" data-canvas="body" id="sidebarCollapse" class="navbar-toggle" data-toggle="offcanvas" data-target="#sidebar" style="color: #393939;margin-top: 9px;">NAVIGATION
                    </A></DIV><DIV class="collapse navbar-collapse" id="bs-example-navbar-collapse-1"><UL class="nav navbar-nav pull-right" style="margin-right:50px"><LI class="dropdown" style="color:#f9f9f9"><A href="https://2018.igem.org/Team:Queens_Canada/Description" style="color:#f9f9f9">Project</A></LI><LI><A href="https://2018.igem.org/Team:Queens_Canada/Description" style="color:#f9f9f9">Overview</A></LI><LI><A href="https://2018.igem.org/Team:Queens_Canada/Background" style="color:#f9f9f9">Background</A></LI></UL><LI class="dropdown" style="color:#f9f9f9"><A href="https://2018.igem.org/Team:Queens_Canada/Lab" style="color:#f9f9f9">Laboratory</A></LI><LI><A href="https://2018.igem.org/Team:Queens_Canada/Lab" style="color:#f9f9f9">Overview</A></LI><LI><A href="https://2018.igem.org/Team:Queens_Canada/Design" style="color:#f9f9f9">Design</A></LI><LI><A href="https://2018.igem.org/Team:Queens_Canada/Experiments" style="color:#f9f9f9">Experiments</A></LI><LI><A href="https://2018.igem.org/Team:Queens_Canada/Demonstrate" style="color:#f9f9f9">Results</A></LI><LI><A href="https://2018.igem.org/Team:Queens_Canada/Improve" style="color:#f9f9f9">Improve</A></LI><LI><A href="https://2018.igem.org/Team:Queens_Canada/Parts" style="color:#f9f9f9">Parts</A></LI><LI><A href="https://2018.igem.org/Team:Queens_Canada/Safety" style="color:#f9f9f9">Safety</A></LI><LI><A href="https://2018.igem.org/Team:Queens_Canada/Notebook" style="color:#f9f9f9">Notebook</A></LI><LI class="dropdown" style="color:#f9f9f9"><A href="https://2018.igem.org/Team:Queens_Canada/Model" style="color:#f9f9f9">Modelling</A></LI><LI><A href="https://2018.igem.org/Team:Queens_Canada/Model" style="color:#f9f9f9">Overview</A></LI><LI><A href="https://2018.igem.org/Team:Queens_Canada/Molecular_Dynamic_Simulations" style="color:#f9f9f9">Molecular Dynamic Simulations</A></LI><LI><A href="https://2018.igem.org/Team:Queens_Canada/Linker_Development" style="color:#f9f9f9">Linker Development</A></LI><LI><A href="https://2018.igem.org/Team:Queens_Canada/Michaelis-Menten_Kinetics" style="color:#f9f9f9">Michaelis-Menten Kinetics</A></LI><LI><A href="https://2018.igem.org/Team:Queens_Canada/Fluid_Dynamics" style="color:#f9f9f9">Fluid Dynamics</A></LI><LI class="dropdown" style="color:#f9f9f9"><A href="https://2018.igem.org/Team:Queens_Canada/Hardware" style="color:#f9f9f9">Hardware</A></LI><LI><A href="https://2018.igem.org/Team:Queens_Canada/Hardware" style="color:#f9f9f9">Overview</A></LI><LI><A href="https://2018.igem.org/Team:Queens_Canada/Pacifier" style="color:#f9f9f9">Pacifier</A></LI><LI><A href="https://2018.igem.org/Team:Queens_Canada/Luminometer" style="color:#f9f9f9">Luminometer</A></LI><LI><A href="https://2018.igem.org/Team:Queens_Canada/Thermistor" style="color:#f9f9f9">Thermistor</A></LI><LI class="dropdown"><A href="https://2018.igem.org/Team:Queens_Canada/Software" style="color:#f9f9f9">Software </A></LI><LI><A href="https://2018.igem.org/Team:Queens_Canada/Software" style="color:#f9f9f9">Overview</A></LI><LI><A href="https://2018.igem.org/Team:Queens_Canada/Luminometer_Software" style="color:#f9f9f9">Luminometer</A></LI><LI><A href="https://2018.igem.org/Team:Queens_Canada/Linker_Software" style="color:#f9f9f9">Linker Software</A></LI><LI class="dropdown" style="color:#f9f9f9"><A href="https://2018.igem.org/Team:Queens_Canada/Human_Practices" style="color:#f9f9f9">Human Practices </A></LI><LI><A href="https://2018.igem.org/Team:Queens_Canada/Human_Practices" style="color:#f9f9f9">Overview</A></LI><LI><A href="https://2018.igem.org/Team:Queens_Canada/Interviews" style="color:#f9f9f9">Expert Interviews</A></LI><LI><A href="https://2018.igem.org/Team:Queens_Canada/Market" style="color:#f9f9f9">Market Analysis</A></LI><LI><A href="https://2018.igem.org/Team:Queens_Canada/Public_Engagement" style="color:#f9f9f9">Education &amp; Engagement</A></LI><LI><A href="https://2018.igem.org/Team:Queens_Canada/Collaborations" style="color:#f9f9f9">Collaborations</A></LI><LI><A href="https://2018.igem.org/Team:Queens_Canada/InterLab" style="color:#f9f9f9">InterLab</A></LI><LI class="dropdown" style="color:#f9f9f9"><A href="https://2018.igem.org/Team:Queens_Canada/Team" style="color:#f9f9f9">QGEM</A></LI><LI><A href="https://2018.igem.org/Team:Queens_Canada/Team" style="color:#f9f9f9">Team</A></LI><LI><A href="https://2018.igem.org/Team:Queens_Canada/Attributions" style="color:#f9f9f9">Attributions</A></LI><LI><A href="https://2018.igem.org/Team:Queens_Canada/Sponsors" style="color:#f9f9f9">Sponsors</A></LI><LI><A href="https://2018.igem.org/Team:Queens_Canada/Entrepreneurship" style="color:#f9f9f9">Entrepreneurship</A></LI></DIV></DIV><NAV id="sidebar" style="z-index: 10001; background-color: white;border: none;box-shadow:1px 0px 0px #393939;" class="navmenu navmenu-default navmenu-fixed-left offcanvas" role="navigation"><A class="navmenu-brand" href="https://2018.igem.org/Team:Queens_Canada"> iGEM TEAM QUEENS CANADA 2018</A><DIV id="sidebarHide" data-toggle="offcanvas" data-target="#sidebar" style="padding-left: 20px;"><A style="font-family: 'Josefin Sans' !important; font-size: 16px; line-height: 18px; height: 18px;"> COLLAPSE NAVIGATION </A></DIV><UL class="nav navmenu-nav" id="sidenav"><LI><A data-toggle="collapse" data-target="#People_side">Project</A></LI><LI><A href="https://2018.igem.org/Team:Queens_Canada/Description">Overview</A></LI><LI><A href="https://2018.igem.org/Team:Queens_Canada/Background">Background</A></LI></UL><LI><A data-toggle="collapse" data-target="#Project_side">Laboratory</A></LI><LI><A href="https://2018.igem.org/Team:Queens_Canada/Lab">Overview</A></LI><LI><A href="https://2018.igem.org/Team:Queens_Canada/Design">Design</A></LI><LI><A href="https://2018.igem.org/Team:Queens_Canada/Experiments">Experiments</A></LI><LI><A href="https://2018.igem.org/Team:Queens_Canada/Demonstrate">Results</A></LI><LI><A href="https://2018.igem.org/Team:Queens_Canada/Improve">Improve</A></LI><LI><A href="https://2018.igem.org/Team:Queens_Canada/Parts">Parts</A></LI><LI><A href="https://2018.igem.org/Team:Queens_Canada/Safety">Safety</A></LI><LI><A href="https://2018.igem.org/Team:Queens_Canada/Notebook">Notebook</A></LI><LI><A data-toggle="collapse" data-target="#Parts_side">Modelling</A></LI><LI><A href="https://2018.igem.org/Team:Queens_Canada/Model">Overview</A></LI><LI><A href="https://2018.igem.org/Team:Queens_Canada/Molecular_Dynamic_Simulations">Molecular Dynamic Simulations</A></LI><LI><A href="https://2018.igem.org/Team:Queens_Canada/Linker_Development">Linker Development</A></LI><LI><A href="https://2018.igem.org/Team:Queens_Canada/Michaelis-Menten_Kinetics">Michaelis-Menten Kinetics</A></LI><LI><A href="https://2018.igem.org/Team:Queens_Canada/Fluid_Dynamics">Fluid Dynamics</A></LI><LI><A data-toggle="collapse" data-target="#Model_side">Hardware</A></LI><LI><A href="https://2018.igem.org/Team:Queens_Canada/Hardware">Overview</A></LI><LI><A href="https://2018.igem.org/Team:Queens_Canada/Pacifier">Pacifier</A></LI><LI><A href="https://2018.igem.org/Team:Queens_Canada/Luminometer">Luminometer</A></LI><LI><A href="https://2018.igem.org/Team:Queens_Canada/Thermistor">Thermistor</A></LI><LI><A data-toggle="collapse" data-target="#AI_side">Software</A></LI><LI><A href="https://2018.igem.org/Team:Queens_Canada/Software">Overview</A></LI><LI><A href="https://2018.igem.org/Team:Queens_Canada/Luminometer_Software">Luminometer</A></LI><LI><A href="https://2018.igem.org/Team:Queens_Canada/Linker_Software">Linker Software</A></LI><LI><A data-toggle="collapse" data-target="#HP_side">Human Practices</A></LI><LI><A href="https://2018.igem.org/Team:Queens_Canada/Human_Practices">Overview</A></LI><LI><A href="https://2018.igem.org/Team:Queens_Canada/Interviews">Expert Interviews</A></LI><LI><A href="https://2018.igem.org/Team:Queens_Canada/Market">Market Analysis</A></LI><LI><A href="https://2018.igem.org/Team:Queens_Canada/Public_Engagement">Education &amp; Engagement</A></LI><LI><A href="https://2018.igem.org/Team:Queens_Canada/Collaborations">Collaborations</A></LI><LI><A href="https://2018.igem.org/Team:Queens_Canada/InterLab">InterLab</A></LI><LI><A data-toggle="collapse" data-target="#Team_side">QGEM</A></LI><LI><A href="https://2018.igem.org/Team:Queens_Canada/Team">Team</A></LI><LI><A href="https://2018.igem.org/Team:Queens_Canada/Attributions">Attributions</A></LI><LI><A href="https://2018.igem.org/Team:Queens_Canada/Sponsors">Sponsors</A></LI><LI><A href="https://2018.igem.org/Team:Queens_Canada/Entrepreneurship">Entrepreneurship</A></LI></NAV><DIV style="width:70%;margin-left:15%" class="column full_size"><H2>Improve</H2><DIV class="column full_size"><P style="font-size:18px"><B>Previous Parts 4-HT Dependent Intein - </B><A href="http://parts.igem.org/Part:BBa_J32009">http://parts.igem.org/Part:BBa_J32009</A></P><P style="font-size:18px">The 4-hydroxytamoxifen (4-HT) dependent intein splices in the presence of 4-HT in Yeast which allows for the ability to control the production 
    of a desired engineered protein in a dose-dependent manner. [1] In the article published by Buskirk et al. (2004), the 4-HT dependent intein was tested and found to be effective in a variety of contexts, including kanamycin resistance, Green Fluorescent Protein, and Beta-galactosidase</P><P style="font-size:18px"><B>Improved Characterization of 4-HT Dependent Intein - </B><A href="http://parts.igem.org/Part:BBa_K2612001">http://parts.igem.org/Part:BBa_K2612001</A></P><P style="font-size:18px"> We tested the ability of the 4-hydroxytamoxifen (4-HT) dependent intein to splice in bacteria, rather than yeast in attempts to improve its characterization, and with the ultimate goal of swapping out the 4-HT dependent intein for a cortisol dependent intein. We constructed the Kanamycin-4HT-Intein in the pET16b vector, and then transformed DH5-alpha. We picked colonies, grew liquid cultures, mini-prepped, and performed a diagonstic digest to confirm our insert was present. 


<FIGURE style="width:50%;margin-left:5%"><FIGCAPTION>See image of Kanamycin-4HT-Intein diagnosstic digest gel, well 1 is a DNA Ladder, well 2 contains empty pET16-B, well 3 shows undigested construct in pet16b, and well 4 shows diagnostic digest confirming construct is present
</FIGCAPTION></FIGURE><FIGURE style="width:50%;margin-right:5%"><FIGCAPTION>Wells 1,3,5,7,9 are undigested pET16b containing the Kanamycin-4HT-intein, and wells 2,4,6,8,10 are pET16b and intein digested with NotI.
</FIGCAPTION></FIGURE></P><P style="font-size:18px">

We then transformed our construct into BL-21 DE3 and induced expression with IPTG. To test intein splicing, we made agar plates containing either 1) Ampicillin, as a positive control, 2) Kanamycin, as a negative control 3) Kanamycin and 4-HT. We plated the BL21 DE3 and found that no bacterial colonies grew on the Kanamycin alone, or Kanamycin and 4-HT containing plates, but there was growth on the Ampicillin containing plates. If the intein was in fact splicing caused by 4-HT, we would expect to see growth on the Kanamycin and 4-HT containing plate. Therefore, this demonstrated that the intein construct was not splicing and Kanamycin Resistance was not being produced. 
<FIGURE style="width:70%;margin-left:15%"><FIGCAPTION> Wells 1,2,3 are incubated without 4-HT and the wells 4,5,6 are incubated with 4-HT. Wells 1 and 4 are the mixed fraction of the bacteria following lysis and sonication. Wells 2, 5 are the soluble fraction. Wells 3 and 6 contain the insoluble pellet. M: Mixed Fraction, S: Soluble Fraction, P: Pellet Fraction
</FIGCAPTION></FIGURE></P><P style="font-size:18px">


To discern why the intein was not splicing we ran a SDS-page on induced BL21-DE3 expression. We grew 2 liquid culture of BL21 DE3, induced expression of T7 RNA polymerase with IPTG, then incubated both for 4 hours at 37C. We then added 10μm 4-HT to one of the liquid cultures and incubated at 37C for an additional 1 hour to allow splicing of the intein to occur.
We then lysed the cells by addition of lysozyme and protease inhibitor containing lysis buffer, followed by sonication for 10 seconds. We then collected 1ml of the mixed fraction, and stored at -20C. We then centrifuged the remainder of the fraction at 8k RPM for 5 minutes, and collected 1ml of the soluble fraction. The remainder of the soluble fraction was tossed, and the insoluble fraction was resuspended and 1 ml was collected as the insoluble fraction.

We then ran a SDS-page to determine protein expression, and if splicing had occured.


We subsequently found one paper that had previously utilized dose-dependent intein splicing in bacteria, however this paper further tagged intein constructs with a maltose-binding protein.[2] Therefore, this further demonstrates the 4-HT dependent intein to be insoluble in Bacteria, unless its solubility is drastically increased through the use of solubility tags such as Maltose-binding protein.
</P><H4>References</H4><OL id="noIndent"><LI>A. R. Buskirk, Y.-C. Ong, Z. J. Gartner, and D. R. Liu, Directed evolution of ligand dependence: small-molecule-activated protein splicing., Proc. Natl. Acad. Sci. U. S. A., vol. 101, no. 29, pp. 10505–10, Jul. 2004.</LI><LI>Skretas G, Wood DW. Regulation of protein activity with small-molecule-controlled inteins. Protein Science : A Publication of the Protein Society. 2005;14(2):523-532. doi:10.1110/ps.04996905.</LI></OL></DIV></DIV></DIV></DIV></DIV></DIV></DIV></BODY></HTML>